The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation

被引:0
|
作者
Mardani, Masoud [1 ]
Abolghasemi, Sara [1 ]
Shabani, Shiva [1 ]
Tavakoli, Farzaneh [2 ]
Saeedi, Anahita [2 ]
Parkhideh, Sayeh [2 ]
Hajifathali, Abbas [2 ]
机构
[1] Shahid Beheshti Univ Medial Sci, Infect Dis & Trop Med Res Ctr, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Hematopoiet Stem Cell Res Ctr, Tehran, Iran
关键词
Cytomegalovirus; Hematopoietic stem cell transplantation; Conditioning regimen; ACUTE MYELOID-LEUKEMIA; REDUCED-INTENSITY; RISK-FACTORS; VIRAL LOAD; INFECTIONS; DISEASE; RELAPSE; MORTALITY; EFFICACY; ERA;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background and Objectives: Infections is yet one of the life-threatening complications of the hematopoietic stem cell transplantation (HSCT). The myeloablative and immunosuppressive conditioning regimens, which are administered before HSCT, dampen the defense capacity of the recipients' immune systems. In this condition, opportunistic infections, especially viral infections such as cytomegalovirus (CMV) can be reactivated and cause morbidity and mortality in HSCT patients. Here, we aimed to find out any possible relationship between types of conditioning regimen and CMV reactivation in allogeneic HSCT patients. Materials and Methods: We retrospectively analyzed the data of 145 CMV-seropositive cases out of total 201 allo-HSCT patients, including age, gender, underlying disease, conditioning regimen, prophylaxis regimen and occurrence of acute graft-versus-host disease (aGVHD) to evaluate their roles in CMV reactivation. Results: Our result showed that conditioning regimen containing Busulfan and Fludarabine (P=0.003) or Cyclophosphamide (P=0.02) significantly decrease the early CMV reactivation. Patients who developed aGVHD (P=0.003) and those who received anti-thymocyte globulin (ATG) as prophylaxis regimen (P=0.002), had 1.84 and 2.63 times higher risks of CMV reactivation, respectively. Conclusion: Our findings suggest the conditioning regimen, aGVHD and ATG as influencing factors for early CMV reactivation post-HSCT which should be considered in the future studies.
引用
收藏
页码:636 / 643
页数:8
相关论文
共 50 条
  • [21] Association between conditioning regimen intensity and nutritional aspects in allogeneic hematopoietic stem cell transplantation in children and adolescents
    Lewandowski, C. G.
    Daudt, L. E.
    Jochims, A. M. K.
    Mello, E. D.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S350 - S350
  • [22] Risk factor analysis for cytomegalovirus reactivation under prophylaxis with letermovir after allogeneic hematopoietic stem cell transplantation
    Mizuno, Kota
    Sakurai, Masatoshi
    Kato, Jun
    Yamaguchi, Kentaro
    Abe, Ryohei
    Koda, Yuya
    Kataoka, Keisuke
    Mori, Takehiko
    TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (06)
  • [23] Improving conditioning regimen prior to allogeneic hematopoietic stem cell transplantation in acute leukaemia
    Greco, Raffaella
    Morelli, Mara
    Giglio, Fabio
    Stanghellini, Maria Teresa Lupo
    Assanelli, Andrea
    Ciceri, Fabio
    Peccatori, Jacopo
    DRUGS AND CELL THERAPIES IN HEMATOLOGY, 2016, 4 (01): : 5 - 13
  • [24] Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis
    Murthy, Guru Subramanian Guru
    Kim, Soyoung
    Estrada-Merly, Noel
    Abid, Muhammad Bilal
    Aljurf, Mahmoud
    Assal, Amer
    Badar, Talha
    Badawy, Sherif M.
    Ballen, Karen
    Beitinjaneh, Amer
    Cerny, Jan
    Chhabra, Saurabh
    DeFilipp, Zachariah
    Dholaria, Bhagirathbhai
    Perez, MiguelAngel Diaz
    Farhan, Shatha
    Freytes, Cesar O.
    Gale, Robert Peter
    Ganguly, Siddhartha
    Gupta, Vikas
    Grunwald, Michael R.
    Hamad, Nada
    Hildebrandt, Gerhard C.
    Inamoto, Yoshihiro
    Jain, Tania
    Jamy, Omer
    Juckett, Mark
    Kalaycio, Matt
    Krem, Maxwell M.
    Lazarus, Hillard M.
    Litzow, Mark
    Munker, Reinhold
    Murthy, Hemant S.
    Nathan, Sunita
    Nishihori, Taiga
    Orti, Guillermo
    Patel, Sagar S.
    van der Poel, Marjolein
    Rizzieri, David A.
    Savani, Bipin N.
    Seo, Sachiko
    Solh, Melhem
    Verdonck, Leo F.
    Wirk, Baldeep
    Yared, Jean A.
    Nakamura, Ryotaro
    Oran, Betul
    Scott, Bart
    Saber, Wael
    HAEMATOLOGICA, 2023, 108 (07) : 1900 - 1908
  • [25] Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell Transplantation
    Prestes, Daniel P.
    Arbona, Esther
    Nevett-Fernandez, Alexandra
    Woolley, Ann E.
    Ho, Vincent T.
    Koo, Sophia
    Baden, Lindsey R.
    Koreth, John
    Hammond, Sarah P.
    Issa, Nicolas C.
    Marty, Francisco M.
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (03) : 510 - 513
  • [26] Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation
    Cesaro, S
    Zhou, X
    Manzardo, C
    Buonfrate, D
    Cusinato, R
    Tridello, G
    Mengoli, C
    Palù, G
    Messina, C
    JOURNAL OF CLINICAL VIROLOGY, 2005, 34 (02) : 129 - 132
  • [27] Cytomegalovirus Reactivation Shapes NK Cells Diversity Following Allogeneic Hematopoietic Stem Cell Transplantation
    Li, Li
    Muftuoglu, Muharrem
    Chen, Han
    Mak, Duncan
    Gokdemir, Elif
    Shaim, Hila
    Burks, Jared
    Daher, May
    Imahashi, Nobuhiko
    Carolina, Mayela
    Vilchez, Mendt
    Basar, Rafet
    Marin, David
    Champlin, Richard E.
    Shpall, Elizabeth J.
    Rezvani, Katayoun
    BLOOD, 2016, 128 (22)
  • [28] Prediction of Cytomegalovirus Reactivation by Recipient Cytomegalovirus-IgG Titer before Allogeneic Hematopoietic Stem Cell Transplantation
    Kawamura, Shunto
    Nakasone, Hideki
    Takeshita, Junko
    Kimura, Shun-Ichi
    Nakamura, Yuhei
    Kawamura, Masakatsu
    Yoshino, Nozomu
    Misaki, Yukiko
    Yoshimura, Kazuki
    Matsumi, Shimpei
    Gomyo, Ayumi
    Akahoshi, Yu
    Kusuda, Machiko
    Kameda, Kazuaki
    Tanihara, Aki
    Tamaki, Masaharu
    Kako, Shinichi
    Kanda, Yoshinobu
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (08): : 683.e1 - 683.e7
  • [29] Impact of natural killer cell reconstitution on outcomes in patients with early cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
    Kanamori, Heiwa
    Ando, Taiki
    Ishiyama, Yasufumi
    Tachibana, Takayoshi
    Tanaka, Masatsugu
    Nakajima, Hideaki
    BONE MARROW TRANSPLANTATION, 2019, 54 : 429 - 430
  • [30] DNA POLYMERASE CHAIN REACTION FOR PLASMA DETECTION OF CYTOMEGALOVIRUS REACTIVATION AFTER AUTOLOGOUS AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Serio, B.
    De Cicco, G.
    Ferri, S.
    Ferrara, I.
    Rosamilio, R.
    Bianco, R.
    Vaccaro, E.
    Bisogno, R. Colella
    Marino, L.
    Guariglia, R.
    Fontana, R.
    Pezzullo, L.
    Martorelli, M. C.
    Selleri, C.
    HAEMATOLOGICA, 2017, 102 : 168 - 168